<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 99 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page98.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=99">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 99 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 99</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=99"><img src="../thumb/99.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>68 / 2020-04                                                   Musculo-Skeletal Agents - 4 / 4.1 / 4.1.1
                                malit., inabil.to concentr., asept. meningit., cognit.dysfunct., convuls.,   Side effects: GI disturbs.ulcerat.& bleed., CNS effs., hypersens.
   4      MUSCULO-SKELETAL      vis.disturbs., corn. opacit., papillit., retrobulb.opt.neurit., papilloed.,   reacts.incl.bronchosp./ angioed./ Stev.Johns.syndr.& tox.epiderm.
                                hear.impairm./-disturbs, tinnit., CHF, hypertens., pulm.oed., palpitat.,
                                                              necrolys., bld. dyscras., ren.fail., palpitat., chest pain, hypertens.,
          AGENTS                vasculit., dyspn., asthma, eosinophil. pneunomit., pancreatit., colit.,   CHF, vis.disturbs., photosens., loc.reacts.
                                aphth.ulc., stomatit., eophagit., intestin.ulcerat., hepatit.incl. fatalit.,
                                                              Special precautions: GI dis., hist.suggest.of GI ulcerat./ulcerat.co-
                                jaund., icter., revers.alopec., photosens./-reacts., porphyr., exudat.  lit., Crohn’s dis, imp.hepat. funct., pre-exist.dyshaemopoiesis, bld.co-
   4.1    Non-steroidal anti-   erythema multiforme, Stev. John.syndr., tox.epiderm. necrolys., ery-  agulat. disords., ren.fail., hepatotox.risk in fem.using for osteoarthrit.,
                                thema nodosum, fix.drug erupt., lich. planus, pustul.react., skin rashes,
                                                              haemorrhag.disords., hypertens., imp.ren./hepat/card.funct., elderly.
          inflammatory agents   SLE, ecchymos., purpura, sweat., interstit., ren.papill.necros., nephrot.  Drug interactions: Li & digox.bld.conc.incr., GI S/E aggrav.by glu-
                                                              cocortic.& other NSAID’s, acetyl salicyl.acid reduc.bioavailabil.& vice
                                syndr., ren.fail./-dis., haematur., proteinur., duct.arterios. clos., fem.in-
          (See also 3.2, 4.3)   fertil., oed., thirst, malaise, rais.ser.creatin., abnorm.LFT, hyperkalaem.  versa, incr. haemorrh.risk with anticoag.ther., hypo-/hyperglycaem.
                                Warnings and special precautions: Avoid concom. NSAID’s ad-  effS.with hypoglycaem.agents, nephrotox.of cyclospor.incr., convuls.
                                min.caref.with GI dis.hist., elderly, imp.ren.funct., low dos.& concom.   report.with quinolones.
   4.1.1   COX inhibitors       protect.agents for GI at risk pts.& concom.low dos.aspir.ther., pts.with   BEDORAL, Ranbaxy (SA) Pty Ltd
                                GI toxic.hist.to report. unusual abdom.sympts., concom.meds.incr.
   PEDEA (MDR Listing)          ulcerat./ bleed.risk, discont.in GI bleed./ulcerat., HF/hypertens.hist.,   See Section 3.2
   VELTEX (MDR Listing)         small incr.risk of arter. thrombot.events report.at high dos.& long term.   BETAPROFEN, Ranbaxy [P/S]
                                ther., concom.acetylsalicyl.acid, discont.in pres.of skin rash/mucos.
   ADCO-DICLOFENAC, AI Pharma Ltd [P/S]  les./hypersens., hist.of angioed./ bronchospast.reactiv./rhinit./nas.  Ibuprofen.
                                                              Indications: Osteo.& rheumat.arthrit., musc. skelet.disords.
   Diclofenac sod.              polyps/allerg.dis./chron.resp.dis.& aspir.sens., hepat.cross reactiv.,   (S3) TABS. X/3.1/366.
   Indications: Fev., dysmenorrh., mild to mod.pain, post-op & post   poss.imp.fem.fertility by eff.on ovulat., concom. analgesics & ster.,   787426-016: 200 mg, 1 000, R145,30
   traumat.inflammat.& swell., ac.gout attacks emerg.treatm.  coagulat.disturbs., meds. influenc.haemostas., intens.diuret.ther.  Dosage: Ac: 1 200-2 400 mg/day in div.dose. Maint: 600-1 200 mg/
   (S2) TABS. U/3.1/181, 182.   Interactions: Cyclosor.conc.incr., Li lev.incr., methotrex. conc.incr.,   day in div.dos. Tot.dly. dos.not to exceed 2 400 mg/day.
   786594-013: 25 mg, 15, R4,27  irrevers.platel.inhib.eff.of acetylsalic.acid poss.attenuat., anticoags.  (S2) FC TABS, 36/3.1/0042
   788597-028: 50 mg, 9, R4,84  eff. enhanc., incr.GI bleed.risk with anti-platel.agents /SSRI’s & cor-  701975-001: 400 mg, 1 000, R263,84
   Dosage: Admin.aft.meals.     ticoster., reduc.diuret.& antihypertens.(incl.ACE inhib.)agents eff.  Indications: Mild to mod.pain of inflammat.origin with/-out fev.
   Mild to mod.pain & inflammat: Adults: 25 mg 3xdly. Max.75 mg   Dosage: Adults: Recomm.dos: 400 mg 8 hrly. Max. tot.dly.dos:
   dly.x5 days..                ARTHREXIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  1200 mg with durat.x5 days.
   Ac.gout attack: 50 mg 3xdly. Max.150 mg dly x3 days.  Indomethacin.  Contraindications: Heart fail., pept.ulc., GI bleed. /-hist./perforat.
   Contraindications: Sensitiv.reacts.like asthma/ ac.rhinit./urticar.to   Indications: Osteo & rheumat.arthrit., ankylos. spondylit., gout.,   relat.to prev.NSAID treatm., act./ recurr.hist.of ulc./haemorrh./perfo-
   aspirin/aspirin-type drugs, pept. ulcerat./hist.therof,   ac.musc.skelet.disord.  rat., aspir./ other NSAID sensitiv., hist.of sev.allerg.reacts.from aspirin/
   Side effects: HF in comprom.pts.due to fluid retent.potent. Freq:   (S3) CAPS, [P/S] K/3.1/285, 286.  other NSAID’s, aspirin induc.nas.polyps assoc. with asthma, childr.
   Headache, dizzin., vertigo., nervousn., epigastr.pain, N&V, diarrh.,   704725-002: 25 mg, 100, R45,19  und.12 yrs., safety in pregn.& lactat.not est.
   abdom. cramps, dyspeps., flatul., anorex., elev.SGOT & SGPT, skin   704725-010: 25 mg, 500, R225,93  Side effects: Ser.skin reacts.incl.exfoliat. dematit. /Stev.-John.syn-
   rash & erupts. Less freq: Bld dyscras., drowsin., vis.disturbs., blurr.  704733-005: 50 mg, 100, R152,82  dr.& tox.epiderm. necrolys., bld. dyscras., CNS effs., blurr.vis., vis.col.
   vis. diplop., imp.hear., tinnit., taste alterat.disords., palpitat., chest   Dosage: Use low.effect.dos.for short.poss.durat.  percept. changes, tox.amblyop., tachycard., flush., hypertens., CF, GI
   pain, hypertens., CHF, gastric/intestin.ulcerat with bleed., aphth.  25 mg 2-3xdly incr.if reqd.by 25-50 mg dly.at wkly interv.up to 150-  disturbs.incl.bleed./pept.ulc., exacerbat. of colit.& Crohn’s dis., hep-
   stomatit., glossit., oesophag.les., diaphragm-like intest.struct., non-  200 mg in div.dos.with food.  atit., fluid retent., oed., imp.ren.funct., hypersens.reacts.
   specif. haemorrhag. colit., ulcerat.colit.exacerbat., Crohn’s dis., con-  (S3) SUPP, [P/S] K/3.1/222.  Special precautions: Sympts.of worsen.infect. poss. mask., hy-
   stipat., pancreatit., hepatit.with/-out jaund., fulmin.hepatit., urticar.,   704741-008: 100 mg, 10, R74,33  pertens., heart fail., GI dis./ulc. hist., elderly, discont.at 1  signs of hy-
                                                                                     st
   prurit., bull.erupt., eczema, erythema multiforme, Stev.-John.syndr.,   Dosage: 100 mg on retir.  persens., reg. use dur.3  trimest.of pregn.may result in persist. pulm.
                                                                       rd
   Lyell’s syndr., exfoliat.dermatit., hair loss, photosens., purpura, oed.,   Contraindications: Pregn., childr., ulcerat. stomach/intest.les.,   hypertens.of newborn & onset of labour delay. & durat. incr., asthma,
   ac.ren.fail., haematur., proteinur., intestin.nephrit., nephrot.syndr.,   ren.& hepat.dis., psychiatr. disords., epilep., Parkinson., acetylsali-  bronchosp., bleed. disords., CV dis., liv./ren.fail., concom.coumar. antico-
   papill.necros., nephropathy with long term use.  cyl. hypersens.  ags, discont.in pres.of vis.changes, incr. asept. mengit. risk with collag.
   Warnings and special precautions: Ren./ hepat.insuffic., sympts.  Side effects: GI disturb., pept.ulcerat., sev. psychos., hallucinat.,   dis., mild reacts. induc. by aspir./other NSAID’s, anaem., stomatit., SLE.
   of GI ulcerat., ulcerat.colit., Crohn’s dis., pre-exist.dyshaematopoies.,   haematopoiet.reacts., CNS eff., allerg.reacts., corneal opacit., vis.  Drug interactions: Act.of anticoags.enhanc., alcoh. /corticoster./
   bld. coagulat.disords., reg.bld.counts, bleed.disords., CV dis., concon.  field chang.  clopidogrel/ticlopidine/ bisphosphonates & pentoxyfylline incr.GI
   coumar.anticoags., safety & effic. in childr & pregn.not est.  Special precautions: Caps & supp.cont.lact.  bleed. risk, antidiab.agents eff.incr., digox.& Li ser. conc. incr., metho-
   Drug interactions: Ser.reacts.with high dose methotrex., Li bld.  Drug interactions: With probenecid & oral anticoag. incr.risk   trex.plasma conc.incr.& prolong., incr. nephrotox.of nephrotox.meds.,
   conc.incr.                   of GI bleed.                  reduct./revers.of antihypertens./diuret.eff., leucopen.&/ thrombocy-
   ADCO-MEFENAMIC ACID, Adcock-Ingram Healthcare (Pty) Ltd  ARTHROTEC, Pfizer [P/S]  topen. eff.of bone marr.depress.incr., anti-platel.agents & SSRI’s incr.
   See Section 3.2              Diclofenac sodium 50 mg, misoprostol 200 mcg.  GI bleed.risk, incr. S/E with two concom.NSAID’s
                                Indications: Osteoarthrit.& rheumat.arthrit.tog. with the prophylax.
   ADCO-NAPROXEN, AI Pharm Ltd [P/S]  of NSAID-induc.gastr.& duod. ulcerat.  BIO DICLOFENAC INJECTION, Biotech [P/S]
   Naproxen.                    (S4) TABS, 28/3.1/0440        Diclofenac sod.
   Indications: Ac.gout attacks for max.5 days in pts.old.than 16 yrs.  813044-006: 20, R102,10  Indications: IM admin: Inflamm.& degen.forms of rheum. dis.,
   (S2) TABS. X/3.1/156.        813044-014: 60, R306,42       mild to mod.painf.inflamm.condit.of non-rheumat.origin, ac.gout
   785245-015: 250 mg, 10, R15,52  Dosage: Swallow whole with food. Do not chew. Low.effect.dos.  attacks. IV infus: Treatm./ prev.of mild to mod.pain of inflam.origin
   Dosage: Gout: 750 mg immed.then 250 mg 8 hrly.  for short.durat.  in absence of infect.
   Contraindications: Pregn.& lactat., act.pept.ulc., NSAID /aspir.  One tab.2-3x dly.  (S3) INJ. 42/3.1/0411 25 mg/ml
   sens., childr.und.16 yrs.    (S4) TABS, 32/3.1/0353        719679-003: 10x 3 ml amps, R21,17
   Side effects: GI disturbs.incl.GI bleed.& pept. ulcerat., skin rash, ur-  Diclofenac sodium 75 mg, misoprostol 200 mcg.  719679-002: 100x 3 ml amps, R219,65
   ticar., anaphylact.reacts., CNS effs., bld.dyscras., tinnit., vis.disturbs.,   869805-002: 30, R177,99  Dosage: Adults: 75 mg dly. deep IM, may be incr.to 2x dly in sev.
   hear. impairm., vertigo, periph.oed., jaund., revers.ren. fail., nephrot.  Dosage: One tab.2x dly.  cas. Max.2 days. Cont.with oral ther./supp.if necess. Admin.low.ef-
   syndr., interstit.nephrit., ulcerat. stomat.  Contra-indications: GI bleed./perforat.hist.relat.to NSAID use,   fect.dos.for short.per.
   Special precautions: GI dis.hist., bronchosp. poss.precipit.in   act./hist.of recurr.ulc./haemorrh/perforat., pregn.& lactat., aspir./  Prepare IV infus.fresh.as per manufact.lit. Do not mix with
   bronch.asthma/allerg.dis., comprom. card.funct., decr.platelet. ag-  other NSAIDs/other prostaglandin. hypersens., HF, safety & effic.  other sol.
   gregat.incr. bleed. time, imp.ren./hepat.funct., elderly, concom.   in childr.not est.  Mod.to sev.post-op pain: 75 mg infus.contin. over 30min.-2 hrs.
   methotrex.                   Side-effects: GI disturbs.incl.bleed., exacerbat. colit.& Crohn’s dis.,   May be repeat. aft.4-6 hrs. Do not exceed tot.dos.of 150 mg/24 hrs.
   Drug interactions: Effs.of highly prot.-bound drugs poss.potent.,   oed., hypertens., CF, papill. necros.& interstit.nephrit., elev.liv.enzym.,   Post-op pain prophylax: 25-50 mg infus.aft. surg. over 15 mins.
   anti-hypertens.eff.of propranol & poss.other ß-block.reduc., natriuret.   menorrhag., intermenstr.vag.bleed., headache, dizzin., skin reacts.  to an hour foll.by contin.infus.of approx.5 mg/hr up to max.dly.
   eff.of furosemide inhibit., ren.Li clear.inhibit., probenecid incr.plasma   incl.exfoliat.dermatit./Stev. John.syndr.& tox.epiderm.necrolys., al-  dos. of 150 mg.
   levels, enhanc.toxic.of methotrex.  lerg.reacts. incl.anaphylax.  Contraindications: IV bolus inj., IV use in imp. ren. funct. &/ any
                                                              form of shock, NSAID/ aspir./ bisulph.sens., gastr./intest.ulc., bleed.
   ALEVE, Bayer Consumer [P/S]  Special precautions: Pre-menopaus.women unless on effect.  disord., GI perf. hist./PUB relat.to prev.NSAID, act./hist.of recurr.
                                contracept., may decr.platel. aggregat.& prolong.bleed.time, com-
   Naproxen sod.                promis.card. funct.condit.predispos.to fluid retent., elderly, ulc./GI dis.  ulc./haemorrh./perforat., asthmat.pts.where asthma attacks/ urti-
   Indications: Short-term treatm.of headache, toothache, musc.pain,   hist., sev.ren./hepat.impairm., monit. ren./hepat.funct.& bld.counts.  car./ac.rhinit.precipit.by acetylsalicyl. acid /other meds.with inhib.
   backache, dysmenorrh., min.aches & pain,assoc.with cold & fev.  Drug interactions: Mg contain.antacids may aggrav.diarrh., 2/  prostagland.-synthet.inhib.activ., childr., porphyr., pregn., HF, est. is-
   (S2) TABS, 31/2.7/0145       more NSAID’s poss.incr.S/E, attenuate natriuret.effic.of diuret., incr.  chaem.heart dis.&/cerebrovasc./ periph. arter.dis.
   (S1) 864692-014: 220 mg, 12, R27,95  serum K+ lev.with K-spar.diuret., poss.plasma Li.& digox. lev.incr., cor-  Side effects: Bld.dyscras., palpitat., chest pain, hypertens., CF, oed.,
   (S2) 864692-015: 220 mg, 24, R55,87  ticoster.incr.GI ulcerat./bleed.risk, anticoags.eff.enhanc., antiplatelet   headache, dizzin., vertigo, CNS effs, convuls., trem., asept.meningit.,
   Dosage: Low.effect.dos for short.durat. Absorpt. poss.delay.by food.   agents & SSRI’s incr.GI bleed.risk, poss.enhancem.of methotrex. toxic.  GI disturbs.incl. ulcerat.& bleed.somet.fatal, colit./ Chron’s dis.exac-
   Not for childr.und.12 yrs. except und.med.supervis.        erbat., glossit., apt.stomatit., oesophag.les., pancreatit., ac.ren.fail.,
   Adults: 1 tab.8-12 hrly.if necess.or an init.dos.of 2 tabs.follow.by   AUSTELL-DICLOFENAC SODIUM, Austell [P/S]  haematur., interstit. nephrit., proteinur., nephrot.syndr., papill. necros.,
   1 tab.12 hrs.later if necess. Max. 3 tabs./24 hrs.x10 consec.days.  Diclofenac sod.  elev.transaminas.lev., hepatit., vis. disturbs., skin reacts.incl.erythema
   Contraindications: Asthma/urticar./allerg.type react.hist.aft.aspi-  Indications: Inflamm.& degen.forms of rheumat. dis., mild to mod.  multiforme/ Stev.John. syndr./tox.epiderm.necrolys., alopec., hyper-
   rin/NSAID admin., GI bleed./ perforat.relat.to prev.NSAID ther., recurr.  painf.inflamm.condit.of non-rheumat. origin.  sens./photosens./loc./psychot.reacts., imp.hear., tinnit., fluid retent.
   act. pept.ulc./haemorrh.hist., sev.HF, pregn.& lactat.,  (S3) INJ. 36/3.1/0405. 25 mg/ml,  Special precautions: Ren./hepat.fail./impairm., elderly esp.very
   Side effects: Common: Dizzin., headache, light headedn., dyspeps.,   704361-002: 75 mg/3 ml, 50x3 ml amps, R79,21  frail/low BM, concom. methotrexate, premat.duct.arteriosus clos in
   naus., heartburn., abdom. pain,. Uncommon: Drowsin., insomn.,   Dosage: Adults: Tot.max.dly.dos:150 mg.  utero /pulm.hypertens.in newborn & delay.labour onset & incr.du-
   somnol., vertigo, diarrh., constip., vomit., skin rash, prurit., urticar.   75 mg deep intra-gluteal IM once dly, may be incr. to 2xdly.in sev.  rat.if admin.in 3  trimest.of pregn., hypertens./ HF hist., may mask
                                                                     rd
   Rare: Pept.ulc.incl.haemorrh.& perforat., GI bleed., hematemes.,   cases.  warn.S&S of infect., hist.suggest.of /GI dis.sympt., ulc.colit., Chron’s
   melena, angioneurot. oed., ren.impairm., periph.oed.partic. with hy-  Contraindications: Gastric/intest.ulc., NSAIDs/ aspir.sensitiv., por-  dis., pre-exist.dyshaemopoies./ bld.coag. disords., CV events risk fact.,
   pertens./ kidn.fail., pyrex. V.rare: Anaphylax. & anaphylact. reacts.  phyr., childr., safety in pregn.& lactat.not est., IV use also in mod.to sev.  HF poss.precipit.in compromis.pts., diuret.-induc.vol.deplet., discont.
   incl.fatal., leucopen., thrombocytopen., agranulocytos, aplast.anaem.,   ren. impairm., hypovolaem., dehydrat., haemorrhag. diathesis hist.,   ther.at first sign of ser.skin reacts./mucos.les./ hypersens./GI bleed.
   eosinophil., haemolyt. anaem., psych. disords., depress., dream abnor-  cerebro-vasc.bleed./suspect. bleed., asthma, surg.with haemorrh.risk.  or ulcer./persist.abnorm.LFT, monit.dur.longt.ther.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page98.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page94.html">94</a>&nbsp;&nbsp;&nbsp;<a href="page95.html">95</a>&nbsp;&nbsp;&nbsp;<a href="page96.html">96</a>&nbsp;&nbsp;&nbsp;<a href="page97.html">97</a>&nbsp;&nbsp;&nbsp;<a href="page98.html">98</a>&nbsp;&nbsp;&nbsp;<a href="page99.html">99</a>&nbsp;&nbsp;&nbsp;<a href="page100.html">100</a>&nbsp;&nbsp;&nbsp;<a href="page101.html">101</a>&nbsp;&nbsp;&nbsp;<a href="page102.html">102</a>&nbsp;&nbsp;&nbsp;<a href="page103.html">103</a>&nbsp;&nbsp;&nbsp;<a href="page104.html">104</a>
             </td>
             <td width="35%"><a href="page100.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page100.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
